← Eichor
Study identifier: NCT07652632 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Regenerative Endoscopy in Refractory Perianal Crohn's Disease

Condition: Crohn Disease (CD) · Perianal Crohns Disease  ·  Sponsor: Asian Institute of Gastroenterology, India

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Perianal fistulizing Crohn's disease (pCD) represents a severe phenotype of Crohn's disease, affecting approximately 20-30% of patients and resulting in chronic drainage, recurrent sepsis, impaired continence, and reduced quality of life. Despite optimization of biologics, antibiotics, and surgical drainage, durable healing remains difficult to achieve. Conventional surgical approaches such as curettage or seton management alone yield modest remission rates, and repeated procedures may compromise sphincter integrity. Autologous mechanically processed tissue stromal vascular fraction (tSVF) is derived from adipose tissue using non enzymatic methods and can be prepared and reinjected during the same operative session. Unlike culture-expanded or enzymatically isolated cell products, mechanical tSVF retains a native adipose micro architecture containing stromal cells, perivascular elements, endothelial progenitors, extracellular matrix components, and bioactive cytokines. This heterogeneous microenvironment is hypothesized to exert immunomodulatory, pro angiogenic, and regenerative effects that may enhance tract healing while preserving sphincter function. Mechanical processing avoids enzymatic digestion, cell expansion, and complex laboratory infrastructure, making it potentially more feasible and cost effective in real world settings. However, high quality prospective data evaluating mechanically processed autologous tSVF specifically in refractory complex pCD remain limited,…

This description comes directly from the study's public registry record.

Talk to the study team

Rajendra Patel, MBBS, DNB, DrNB  ·  +918152049069  ·  doc.rajendrapatel@gmail.com

Goutham R Katukuri, MBBS, MD, DM  ·  +919902305703  ·  goutham.mge@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

AIG HospitalsHyderabad, Telangana, IndiaRecruiting
AIG HospitalsHyderabad, Telangana, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07652632